PRESS RELEASE published on 05/11/2026 at 11:09, 4 months 10 days ago Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market, targeting niche patient populations and high-need therapeutic areas with a strategic commercial milestone Marinomed Biotech AG Marinosolv Technology Tacrolimus Eyedrops Compounding Market Ophthalmologists
BRIEF published on 04/22/2026 at 09:09, 4 months 29 days ago Marinomed Biotech AG Expands into Compounding Services Global Expansion Marinomed Biotech Marinosolv Technology Compounding Services Customized Medicines
BRIEF published on 04/22/2026 at 09:09, 4 months 29 days ago Marinomed Biotech AG se développe dans le domaine des services de préparation magistrale Expansion Mondiale Technologie Marinosolv Biotechnologie Marinomed Services De Préparation Magistrale Médicaments Personnalisés
PRESS RELEASE published on 04/22/2026 at 09:04, 4 months 29 days ago Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology Marinomed Biotech AG announces strategic expansion into compounding services with Marinosolv technology, offering personalized medicines for global demand Marinomed Biotech AG Strategic Expansion Marinosolv Technology Compounding Services Personalized Medicines
BRIEF published on 04/13/2026 at 17:07, 5 months 8 days ago Marinomed Biotech AG finalise avec succès son augmentation de capital Augmentation De Capital Confiance Des Investisseurs Bourse De Vienne Actions Émises Biotechnologie Marinomed
BRIEF published on 04/13/2026 at 17:07, 5 months 8 days ago Marinomed Biotech AG Completes Successful Capital Increase Capital Increase Investor Confidence Vienna Stock Exchange Marinomed Biotech Shares Issued
PRESS RELEASE published on 04/13/2026 at 17:02, 5 months 8 days ago Marinomed secures financing through successful capital increase Marinomed Biotech AG successfully completes capital increase, securing EUR 2.23 million in gross proceeds. Financing to support company's milestones and flagship products marketing Financing Capital Increase Marinomed Biotech AG Rights Offering Marinosolv Technology
BRIEF published on 03/23/2026 at 17:49, 5 months 29 days ago Marinomed Biotech AG: Capital Increase and 2025 Financial Outlook Capital Increase Marinomed 2025 Results Liquidity Gap Shareholder Opportunity
BRIEF published on 03/23/2026 at 17:49, 5 months 29 days ago Marinomed Biotech AG : Augmentation de capital et perspectives financières pour 2025 Augmentation De Capital Marinomed Résultats 2025 Déficit De Liquidités Opportunité Pour Les Actionnaires
PRESS RELEASE published on 03/23/2026 at 17:44, 5 months 29 days ago Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research issues a Buy recommendation with a target price of EUR 50 for Marinomed Biotech AG due to a capital increase and delayed Carragelose earn-out revenues First Berlin Equity Research Buy Recommendation Capital Increase Marinomed Biotech AG Carragelose Earn-out
Published on 09/21/2026 at 15:45, 7 hours 43 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 9 hours 8 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 9 hours 23 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 9 hours 28 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 9 hours 43 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 22:05, 1 hour 23 minutes ago Abivax Presents Business Updates and First Half 2026 Financial Results
Published on 09/21/2026 at 22:05, 1 hour 23 minutes ago Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026
Published on 09/21/2026 at 20:34, 2 hours 53 minutes ago BRANICKS Group AG: Regular interest payment on EUR 400 million bond to be made as scheduled – Completion of maturity extension imminent
Published on 09/21/2026 at 19:00, 4 hours 28 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 14 septembre 2026 au 18 septembre 2026
Published on 09/21/2026 at 18:00, 5 hours 28 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 09/21/2026 at 18:19, 5 hours 8 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 5 hours 8 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 5 hours 26 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 5 hours 42 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 5 hours 42 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026
